Clinical Trial Update: Low dosE GlibENclamide in Diabetes Part A [Phase 2]

View source ↗

Summary

Phase 2 trial of low-dose glibenclamide for type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glibenclamide (glibenclamide)

Snippet

Sponsor: University of Oxford | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED